Veru
Miami
About Veru
Veru is a biopharmaceutical company that focuses on infectious diseases and oncology. They develop novel medicines for COVID-19 and other viral and ARDS-related diseases and for the management of breast and prostate cancers. Their development portfolio includes sabizabulin, enobosarm, zuclomiphene citrate, and more.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $158.2M
- Funding stage: IPO
- Last round: Post-IPO Equity (Oct 2025)
- Ticker: nasdaq:VERU
- Website: verupharma.com
- Phone: +1 305 509 6897
Industries & Categories
Biopharma, Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/veru-21765 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.